Home ETF List About

Portfolio Holdings Detail for ISIN IE00BFNM3J75
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 77
Stock Name / FundiShares MSCI World ESG Screened UCITS ETF
IssuerBlackrock
ETF TickerSNAW(EUR) F
ETF TickerSAWD.LS(USD) CXE
ETF TickerSAWD.MI(EUR) CXE
ETF TickerSAWDx(GBP) CXE
ETF TickerSAWDz(USD) CXE
ETF TickerSNAW.DE(EUR) CXE
ETF TickerSAWD(EUR) ETF Plus

Holdings detail for LLY

Stock NameEli Lilly and Company
TickerLLY(EUR) F
TYPECommon Stock
CountryGermany
ISINUS5324571083
LEIFRDRIPF3EKNDJ2CQJL29

Show aggregate LLY holdings

News associated with LLY

Notable Friday Option Activity: AMD, LLY, BKNG
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Advanced Micro Devices Inc (Symbol: AMD), where a total volume of 570,924 contracts has been traded thus far today, a contract volume which is representative of a - 2025-09-19 14:45:00
Boost Your Portfolio With These Top-Ranked ETFs
With the Fed's first 2025 rate cut and upgraded growth outlook, ETFs in tech, financials, industrials and health care could benefit from momentum. - 2025-09-19 13:03:00
3 Dividend Growth Stocks You Can Buy and Forget About
Key PointsThese stocks offer seemingly low yields of less than 1%. - 2025-09-18 05:50:00
JPMorgan Chase & Co. Has Lowered Expectations for Eli Lilly and Company (NYSE:LLY) Stock Price
Eli Lilly and Company (NYSE:LLY – Get Free Report) had its price objective decreased by JPMorgan Chase & Co. from $1,100.00 to $1,050.00 in a research report issued on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 38.09% from the […] - 2025-09-18 02:56:56
Lilly's Orforglipron Achieves Significant Weight Loss In Phase 3 Trial
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from its Phase 3 ATTAIN-1 trial, evaluating the safety and efficacy of orforglipron—an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist—in adults with obesity, or those overweight with a weight-re - 2025-09-17 00:35:16
XLV, LLY, TMO, PFE: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the The Health Care Select Sector SPDR Fund (Symbol: XLV) where we have detected an approximate $308.0 million dollar inflow -- that's a 0.9% increase we - 2025-09-16 11:47:58
S&P 500 Analyst Moves: LLY
The latest tally of analyst opinions from the major brokerage houses shows that among the components of the S&P 500 index, Eli Lilly is now the #61 analyst pick, moving up by 1 spot. This rank is formed by averaging the analyst opinions for each component from each - 2025-09-15 14:35:56
Why Novo Nordisk Stock Popped Today
Key PointsLondon's Financial Times highlights improved weight loss from taking more Ozempic. - 2025-09-15 12:34:46
Sen. John Boozman Buys Eli Lilly and Company (NYSE:LLY) Stock
Senator John Boozman (R-Arkansas) recently bought shares of Eli Lilly and Company (NYSE:LLY). In a filing disclosed on September 12th, the Senator disclosed that they had bought between $1,001 and $15,000 in Eli Lilly and Company stock on August 11th. Senator John Boozman also recently made the following trade(s): Purchased $1,001 – $15,000 in shares […] - 2025-09-15 03:12:42
3 Monster Stocks to Hold for the Next 5 Years
Key PointsAmazon should improve its profits and margins, based on its cloud computing and AI initiatives. - 2025-09-14 08:45:00
2 Beaten-Down Stocks to Buy and Hold Forever
Key PointsApple and Eli Lilly have impressive long-term track records of returns. - 2025-09-13 08:45:00
2 Monster Stocks to Hold for the Next 5 Years
Key PointsThese stocks have climbed in the triple digits over the past three years. - 2025-09-11 05:20:00
IWB, LLY, ORCL, CVX: Large Inflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 1000 ETF (Symbol: IWB) where we have detected an approximate $462.9 million dollar inflow -- that's a 1.1% increase week over week in - 2025-09-08 12:03:03
Down 34%, Should You Buy the Dip on Viking Therapeutics?
Key PointsViking Therapeutics is working on an injectable weight loss drug candidate and one in pill format. - 2025-09-05 05:10:00
The 6 Best Stocks to Buy Right Now in September (2025)!
My list of best stocks to buy has outperformed the broader market indexes by a significant margin. - 2025-09-04 06:00:00
The Problem With Weight Loss Stocks
In this Motley Fool Money episode, Motley Fool analysts Rick Munarriz and Karl Thiel and contributor Jason Hall dig into the problems with weight loss stocks. They also look at some investments that can survive near-term potential volatility as well as give a long-term view of di - 2025-09-03 14:48:00
NVO's Wegovy vs. LLY's Tirzepatide: Who Leads in Heart Risk Reduction?
Novo Nordisk's Wegovy shows a stronger reduction in heart risks compared to Eli Lilly's tirzepatide in real-world data from the STEER study. - 2025-09-01 11:54:00
The Zacks Analyst Blog Highlights Lilly, Oracle, Procter & Gamble and Comstock Holding Companies
Zacks spotlights Eli Lilly, Oracle, Procter & Gamble, and microcap Comstock Holding, with pharma and staples facing pressure while Oracle and Comstock show momentum. - 2025-08-29 13:58:00
Nvidia's $46.7 Billion Quarter Shows the AI Trade Is Alive and Well -- With Caveats
Key PointsWhile earnings were up 56%, the company's data center revenue dropped 1% sequentially. - 2025-08-29 05:45:00
Top Stock Reports for Eli Lilly, Oracle & Procter & Gamble
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly, Oracle, and Procter & Gamble, as well as a micro-cap stock, Comstock. - 2025-08-28 18:59:00
2 Growth Stocks That Could Be Worth $1 Trillion in 5 Years
Key PointsEli Lilly's work in weight management should help it surpass some industry sales records. - 2025-08-28 10:45:00
2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
Key PointsDividend-paying stocks tend to outperform non-dividend-paying stocks by a mile. - 2025-08-28 04:26:00
As the Market Rotates, This Healthcare ETF Is Leading the Way
Over the past month, the market has undergone a rotation that’s seen tech sell-off and defensive sectors like healthcare reap the rewards. The jury remains out on whether this shift indicates a more inclusive rally or if it should raise questions about the bull market’s footing. - 2025-08-26 10:35:00
When AI Execs Say the Market Looks Bubbly
In this podcast, Motley Fool contributors Tyler Crowe, Lou Whiteman, and Rachel Warren discuss: - 2025-08-25 14:47:00
Eli Lilly and Company (NYSE:LLY) and Innoviva (NASDAQ:INVA) Financial Analysis
Eli Lilly and Company (NYSE:LLY – Get Free Report) and Innoviva (NASDAQ:INVA – Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, risk, dividends and earnings. Institutional & Insider Ownership 82.5% of Eli […] - 2025-08-25 04:38:49
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
Key PointsThe S&P 500's rising yield is similar to what happened before the dot-com bubble burst. - 2025-08-24 15:23:00
The Best Stocks to Invest $50,000 in Right Now
Key PointsIf you have a lump sum of money, look for long-term performance and stability. - 2025-08-24 05:32:00
If I Could Only Buy 1 S&P 500 Stock From Each Sector for the Rest of 2025, I'd Go With These 11 Dividend Stocks
Key PointsSome stock market sectors significantly impact the S&P 500, whereas others barely make a dent. - 2025-08-23 19:05:00
Is the Vanguard Mega Cap ETF the Simplest Way to Invest in the Top S&P 500 Stocks?
Key PointsThe fund targets the 37% largest S&P 500 components by market cap. - 2025-08-23 17:05:00
Warren Buffett Makes a Big Buy
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rick Munarriz discuss: - 2025-08-22 17:55:00

iShares MSCI World ESG Screened UCITS ETF LLY holdings

DateNumber of LLY Shares HeldBase Market Value of LLY SharesLocal Market Value of LLY SharesChange in LLY Shares HeldChange in LLY Base ValueCurrent Price per LLY Share HeldPrevious Price per LLY Share Held
2025-11-11 (Tuesday)64,118USD 63,388,337LLY holding increased by 1409313USD 63,388,3370USD 1,409,313 USD 988.62 USD 966.64
2025-11-10 (Monday)64,118USD 61,979,024LLY holding increased by 2710268USD 61,979,0240USD 2,710,268 USD 966.64 USD 924.37
2025-11-07 (Friday)64,118USD 59,268,756LLY holding decreased by -838022USD 59,268,7560USD -838,022 USD 924.37 USD 937.44
2025-11-06 (Thursday)64,118USD 60,106,778LLY holding increased by 745692USD 60,106,7780USD 745,692 USD 937.44 USD 925.81
2025-11-05 (Wednesday)64,118USD 59,361,086LLY holding increased by 1877375USD 59,361,0860USD 1,877,375 USD 925.81 USD 896.53
2025-11-03 (Monday)64,118USD 57,483,711LLY holding increased by 2158854USD 57,483,7110USD 2,158,854 USD 896.53 USD 862.86
2025-10-31 (Friday)64,118USD 55,324,857LLY holding increased by 1177206USD 55,324,8570USD 1,177,206 USD 862.86 USD 844.5
2025-10-30 (Thursday)64,118LLY holding increased by 1677USD 54,147,651LLY holding increased by 2939787USD 54,147,6511,677USD 2,939,787 USD 844.5 USD 820.1
2025-10-28 (Tuesday)62,441USD 51,207,864LLY holding decreased by -394003USD 51,207,8640USD -394,003 USD 820.1 USD 826.41
2025-10-27 (Monday)62,441LLY holding increased by 387USD 51,601,867LLY holding increased by 379393USD 51,601,867387USD 379,393 USD 826.41 USD 825.45
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LLY by Blackrock for IE00BFNM3J75

Show aggregate share trades of LLY

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-30BUY1,677853.000812.250 816.325EUR 1,368,977 803.71
2025-10-27BUY387826.410826.420 826.419EUR 319,824 803.52
2025-10-22BUY258812.430815.940 815.589EUR 210,422 803.28
2025-10-16BUY258819.380834.700 833.168EUR 214,957 803.19
2025-09-18SELL-348762.930772.540 771.579EUR -268,509 804.63 Profit of 11,502 on sale
2025-09-17BUY387760.130776.960 775.277EUR 300,032 804.87
2025-08-21SELL-1,032709.820718.400 717.542EUR -740,503 806.49 Profit of 91,797 on sale
2025-07-16SELL-129789.800796.040 795.416EUR -102,609 810.69 Profit of 1,971 on sale
2025-07-15BUY129771.750805.420 802.053EUR 103,465 810.92
2025-07-08SELL-258777.660792.690 791.187EUR -204,126 811.57 Profit of 5,259 on sale
2025-06-17BUY361791.240805.160 803.768EUR 290,160 814.44
2025-06-09BUY129773.710779.290 778.732EUR 100,456 814.84
2025-05-30BUY570737.670745.900 745.077EUR 424,694 817.38
2025-05-29SELL-254722.570727.330 726.854EUR -184,621 818.06 Profit of 23,167 on sale
2025-05-20BUY254747.010763.500 761.851EUR 193,510 823.16
2025-05-16BUY508757.390758.870 758.722EUR 385,431 824.19
2025-05-14BUY486715.560759.500 755.106EUR 366,982 825.76
2025-05-13SELL-762746.060759.500 758.156EUR -577,715 826.40 Profit of 52,000 on sale
2025-05-08SELL-254751.450769.980 768.127EUR -195,104 828.33 Profit of 15,291 on sale
2025-04-25SELL-127884.540885.580 885.476EUR -112,455 827.61 Loss of -7,349 on sale
2025-04-15BUY1,143757.180765.310 764.497EUR 873,820 828.69
2025-04-11SELL-635732.410735.840 735.497EUR -467,041 830.33 Profit of 60,217 on sale
2025-04-10BUY254720.910741.950 739.846EUR 187,921 831.39
2025-04-09BUY381753.710754.830 754.718EUR 287,548 832.15
2025-04-08SELL-580726.240763.500 759.774EUR -440,669 833.20 Profit of 42,587 on sale
2025-04-07SELL-348723.730748.000 745.573EUR -259,459 834.29 Profit of 30,875 on sale
2025-03-28SELL-381822.510829.780 829.053EUR -315,869 835.99 Profit of 2,644 on sale
2025-03-27BUY94821.670826.770 826.260EUR 77,668 836.15
2025-03-13BUY127801.650821.110 819.164EUR 104,034 836.60
2025-03-05SELL-254929.720930.490 930.413EUR -236,325 835.43 Loss of -24,125 on sale
2025-02-28BUY560920.630921.220 921.161EUR 515,850 832.08
2025-02-26BUY378915.010922.430 921.688EUR 348,398 829.97
2025-02-19BUY504867.050881.330 879.902EUR 443,471 826.38
2025-02-14BUY756844.270873.500 870.577EUR 658,156 825.38
2025-02-13BUY367871.860883.500 882.336EUR 323,817 824.66
2025-02-12BUY252872.970877.780 877.299EUR 221,079 823.91
2025-02-10BUY630868.880880.000 878.888EUR 553,699 822.52
2025-02-07BUY252878.310889.360 888.255EUR 223,840 821.60
2025-02-05BUY126842.180846.900 846.428EUR 106,650 820.43
2025-02-04BUY230826.070829.040 828.743EUR 190,611 820.33
2025-01-23BUY126766.600766.600 766.600EUR 96,592 823.30
2024-12-10BUY378799.580814.000 812.558EUR 307,147 823.79
2024-12-09BUY126803.580823.700 821.688EUR 103,533 824.21
2024-12-04BUY126829.840846.460 844.798EUR 106,445 824.00
2024-11-26BUY126789.320807.000 805.232EUR 101,459 829.38
2024-11-26BUY126789.320807.000 805.232EUR 101,459 829.38
2024-11-21BUY232749.920753.000 752.692EUR 174,625 838.48
2024-11-20BUY252753.410757.370 756.974EUR 190,757 841.06
2024-11-19BUY756729.730730.000 729.973EUR 551,860 844.54
2024-11-18BUY1,724727.200734.000 733.320EUR 1,264,244 848.32
2024-11-11BUY504832.440844.000 842.844EUR 424,793 850.51
2024-11-11BUY504832.440844.000 842.844EUR 424,793 850.51
2024-11-06BUY378776.380820.730 816.295EUR 308,560 863.80
2024-11-06BUY378776.380820.730 816.295EUR 308,560 863.80
2024-10-29BUY126903.580907.980 907.540EUR 114,350 898.10
2024-10-29BUY126903.580907.980 907.540EUR 114,350 898.10
2024-10-28BUY126895.590898.210 897.948EUR 113,141 898.73
2024-10-28BUY126895.590898.210 897.948EUR 113,141 898.73
2024-10-22BUY882909.150911.120 910.923EUR 803,434 906.13
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LLY

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19432,0389351,319,85332.7%
2025-09-18547,8181261,290,14742.5%
2025-09-17437,3374271,166,20437.5%
2025-09-16532,6981,8291,463,37436.4%
2025-09-15424,9797011,071,48739.7%
2025-09-12267,121172826,80232.3%
2025-09-11249,8031,484850,46129.4%
2025-09-10415,4421,025989,00842.0%
2025-09-09559,8056671,270,80044.1%
2025-09-08856,0184,6821,937,44744.2%
2025-09-05679,2761,0501,405,23948.3%
2025-09-04337,49153982,75134.3%
2025-09-03214,691496766,15728.0%
2025-09-02430,4772,9771,131,90838.0%
2025-08-29357,538602889,50940.2%
2025-08-28433,6871,0991,113,56838.9%
2025-08-27860,7156,0091,681,35351.2%
2025-08-261,548,46012,1052,955,34852.4%
2025-08-25566,4543,5861,323,24942.8%
2025-08-22749,6151,9571,460,71351.3%
2025-08-21651,6392231,570,06741.5%
2025-08-20679,5542,6981,870,24136.3%
2025-08-19787,9099352,788,74028.3%
2025-08-18756,1431,0951,727,60343.8%
2025-08-151,814,7218363,422,26053.0%
2025-08-141,852,9405,3823,602,82951.4%
2025-08-131,254,2253,4732,774,10045.2%
2025-08-12990,1103,1902,845,89634.8%
2025-08-111,290,0631,6155,196,30224.8%
2025-08-082,448,706300,8706,239,83039.2%
2025-08-074,197,951489,61810,364,29440.5%
2025-08-06440,1441,1201,811,26224.3%
2025-08-05331,460921993,17833.4%
2025-08-04474,9051,4081,273,99537.3%
2025-08-01530,5697,1391,882,09828.2%
2025-07-31882,5063,6702,110,03041.8%
2025-07-30745,6143921,827,43540.8%
2025-07-291,081,8495712,607,24541.5%
2025-07-28304,8417,4601,004,03230.4%
2025-07-25365,4172651,055,27334.6%
2025-07-24321,7997621,167,14727.6%
2025-07-23485,7193,4711,044,91946.5%
2025-07-22241,0983,036874,71727.6%
2025-07-21418,0148541,180,44535.4%
2025-07-18623,4986511,225,33350.9%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.